13D/13G Filings - Elicio Therapeutics Inc. (ELTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-04-27
4:08 pm
Purchase
2021-02-04 13D Angion Biomedica Corp.
ANGN
Elicio Therapeutics Inc.
ELTX
290,174
9.300%
290,174increase
(New Position)
Filing
History
2022-03-30
3:51 pm
Purchase
2021-02-09 13G Angion Biomedica Corp.
ANGN
Vifor (International) Ltd. 199,564
6.700%
199,564increase
(New Position)
Filing
History
2022-02-14
5:29 pm
Purchase
2021-12-31 13G Angion Biomedica Corp.
ANGN
EISA-ABC LLC 172,224
5.700%
172,224increase
(New Position)
Filing
History
Goto Prev, 0, 1